Skip to main content
TipRanks
Go Ultimate75% OFF

EyePoint Pharmaceuticals (PV3B) Ownership - Who Owns EyePoint Pharmaceuticals?

1 Followers

EyePoint Pharmaceuticals (PV3B) Ownership Overview

  • 7.94% Insiders
  • 14.18% Mutual Funds
  • 38.36% Other Institutional Investors
  • 10.31% ETFs
  • 29.20% Public Companies and Individual Investors

The ownership structure of EyePoint Pharmaceuticals (DE:PV3B) stock is a mix of institutional, retail, and individual investors. Approximately 62.86% of the company’s stock is owned by Institutional Investors, 7.94% is owned by Insiders, and 29.20% is owned by Public Companies and Individual Investors.

Institutional holdings as of (latest 13F reporting period).

Recent Insider Trading Activity

Recent Insider Trading Activity
DateNameActivityValue
Aug 17, 2026Karen Zaderej$52,258
Jul 01, 2026Ramiro Ribeiro$73,149
Apr 19, 2026Ramiro Ribeiro$36,555
Mar 15, 2026Jay Duker$19,710

Recent Hedge Fund Trading Activity

Recent Hedge Fund Trading Activity
DateFirmActivityValue
Dec 31, 2025Woodline Partners Lp€1,835,459

Top Shareholders

DE:PV3B top shareholders
Holder# of SharesType% HoldingValue
Cormorant Asset Management, Llc8,265,000Insider7.26%2,281,140
BlackRock, Inc.7,982,162Institution7.02%2,203,077
Federated Hermes Equity Funds4,760,141Institution4.18%1,313,799
Ishares4,528,681Institution3.98%1,249,916
Vanguard3,777,666Institution3.32%1,042,636
Vanguard Index Funds3,539,772Institution3.11%976,977
Franklin Strategic Series2,207,989Institution1.94%609,405
Spdr1,444,274Institution1.27%398,620
Mutual Fund Series Trust1,245,583Institution1.09%343,781
Fidelity Salem Street Trust937,199Institution0.82%258,667

Top Mutual Fund Holders

DE:PV3B top mutual fund holders
Holder# of SharesType% HoldingValue
Federated Hermes Equity Funds4,760,141Institution4.18%1,313,799
Vanguard Index Funds3,539,772Institution3.11%976,977
Franklin Strategic Series2,207,989Institution1.94%609,405
Mutual Fund Series Trust1,245,583Institution1.09%343,781
Fidelity Salem Street Trust937,199Institution0.82%258,667
Fidelity Concord Street Trust785,131Institution0.69%216,696
Federated Hermes Mdt Series621,538Institution0.55%171,544
Vanguard Scottsdale Funds531,109Institution0.47%146,586
Dfa Investment Dimensions Group Inc393,027Institution0.35%108,475
Tiaa-cref Funds242,353Institution0.21%66,889

FAQ

Who Owns EyePoint Pharmaceuticals (DE:PV3B)?
According to the latest TipRanks data (13F holdings as of December 31, 2025), approximately 62.86% of the company's stock is held by institutional investors, 7.94% is held by insiders, and 29.20% is held by public companies and individual investors.
What percentage of EyePoint Pharmaceuticals (DE:PV3B) stock is held by institutional investors?
According to the latest TipRanks data (13F holdings as of December 31, 2025), approximately 62.86% of EyePoint Pharmaceuticals (DE:PV3B) stock is held by institutional investors: 14.18% by mutual funds, 10.31% by ETFs and 38.36% by other institutional investors.
What percentage of EyePoint Pharmaceuticals (DE:PV3B) stock is held by retail investors?
According to the latest TipRanks data (13F holdings as of December 31, 2025), approximately 29.20% of EyePoint Pharmaceuticals (DE:PV3B) stock is held by public companies and individual investors.
Who owns the most shares of EyePoint Pharmaceuticals (DE:PV3B)?
Cormorant Asset Management, LLC owns the most shares of EyePoint Pharmaceuticals (DE:PV3B).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.